Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalData Regulatory News (DATA)

Share Price Information for GlobalData (DATA)

Share Price is delayed by 15 minutes
Get Live Data
96.50    -6.90 (-6.67%)
Bid:
96.10
Ask:
96.70
Spread: 0.60 (0.624%)
Market Cap: £671.98m
DATA Live PriceLast checked at - London Stock Exchange

Intraday GlobalData Share Chart

Trading Statement

14 Jan 2025 07:00

RNS Number : 1646T
GlobalData PLC
14 January 2025
 

14 January 2025

GlobalData Plc

(AIM: DATA, "GlobalData", the "Group")

 

Full year trading update

 

Trading in line with market expectations

 

Strong momentum with M&A

 

GlobalData Plc ('GlobalData' or the 'Group'), a leading data, analytics, insights and technology platform, today provides this update following the end of its financial year to 31 December 2024 ("FY24").

 

Trading

 

Following its interim results on 31 July 2024, GlobalData continued to deliver strong, profitable growth throughout the second half of the year.

 

For FY24, the Group expects to report Group revenue of c.£286m, within the range of market expectations for the year* (2023: £273m), and up 4% on an underlying basis. Adjusted EBITDA is also expected to be within the range of market expectations, representing growth of c.6% ahead of FY23 with a sustained margin of c.41% following our continued planned investment in the Growth Transformation Plan (2023: 41%).

 

The Group closed the year with underlying Contracted Forward Revenue ("CFR") growth of 4%, providing strong visibility into 2025 (CFR includes both Invoiced Forward Revenue and contracted revenue un-invoiced as at 31 December 2024).

 

FY24 was a significant year of investment across our Growth Transformation Plan initiatives. We continued to invest in our AI capabilities, delivering demonstrable client impact with a 60% increase in AI Hub usage, as well as launching our new client solutions offerings. As at 31 December 2024, we had a strong increase in sales headcount versus the same point last year, which included an additional 30 senior sales positions.

 

Following the completion of our transaction with Inflexion in June 2024 to support growth through a bolt-on M&A strategy, the Group closed four M&A transactions during the second half of FY24 (BTMI, LinkUp, Celent and Deallus) for a combined purchase price of c.£86m (of which £32m was in Healthcare). In aggregate these acquisitions will add c.£42m of revenues during FY25 (of which £13m will be in Healthcare) and c.£6m of Adjusted EBITDA (£2m within Healthcare).

 

In addition to M&A, the Group has deployed capital towards share buybacks in the second half. During H2, we purchased shares to the value of c.£29m across two buy-back programmes which were purchased into treasury and subsequently cancelled. Additionally, the Group's Employee Benefit Trust bought £29m of shares, to satisfy future share scheme exercises. 

 

Net cash reduced from £188m at 30 June 2024 to c.£2m as at 31 December 2024 (2023: Net Debt £244m). This movement largely reflects the deployment of capital on M&A (c.£86m), share buy backs (c.£57m), plus £26m of expenses for the Inflexion transaction that were unpaid at the half year that were settled in H2. The Group announced new £340m financing facilities in December and therefore has significant firepower to further execute against its M&A strategy.

 

Outlook

 

The Board is confident in GlobalData's outlook for 2025, underpinned by high levels of revenue visibility, good execution of the Growth Transformation Plan and a strong financial position that allows continued investment in strategic growth opportunities.

 

FY24 results will be announced in full on 10 March 2025.

 

Mike Danson, Chief Executive Officer of GlobalData Plc, commented:

 

"2024 has been a year of investment for GlobalData and we have made significant progress in our first year of executing the Growth Transformation Plan 2024-26. Our mission-critical data and insights remain vital to our global customers, demonstrated by our strong, profitable growth in 2024, delivering an EBITDA margin of 41%.

 

Our AI advancements have transformed how customers access insights. With our platform's generative AI capabilities, customers can now access trusted, actionable intelligence with the touch of a button, giving them the information they need to make informed decisions, navigate complexity with confidence, and achieve measurable business success.

 

Following the arrangement of new £340m financing facilities in December, we have substantially bolstered our ability to execute our ambitious M&A strategy. Four strategic acquisitions have been completed during the second half with expertise spanning healthcare, financial services and media. Integrating these businesses into our platform will enhance our capability to deliver even better service and valuable insights for our clients.

 

In addition to strategically deploying capital to advance our world-class products through M&A, we remain focused on actively pursuing organic growth opportunities.

 

We enter 2025 from a position of strength with good revenue visibility and the firepower to execute on our strategy. We continue to progress towards our targets of 45% margin and £500m revenue by the end of the three-year growth plan." 

 

*GlobalData's compiled market expectations consensus as at 31 December 2024 is as follows: Revenue range £285.5m - £288.1m and Adjusted EBITDA range of £117.0m - £123.3m

 

ENDS

ENQUIRIES

 

GlobalData Plc

Mike Danson, Chief Executive Officer

0207 936 6400

Graham Lilley, Chief Financial Officer

 

J.P. Morgan Cazenove (Nomad, Joint Broker)

0203 493 8000

Bill Hutchings

Mose Adigun

 

Panmure Liberum (Joint Broker)

0203 100 2000

Rupert Dearden

Dougie McLeod

 

Investec Bank plc (Joint Broker)

Henry Reast

Virginia Bull

 

0207 597 5970

FTI Consulting (Financial PR)

0203 727 1000

globaldata@fticonsulting.com

Edward Bridges

Dwight Burden

Emma Hall

 

About GlobalData Plc   GlobalData Plc (AIM: DATA) is a leading data, analytics, insights and technology platform for the world's largest industries. Our mission is to help our clients decode the future, make better decisions, and reach more customers. 

 

One Platform Model 

GlobalData's One Platform model is the foundation of our business and is the result of years of continuous investment, targeted acquisitions, and organic development. This model governs everything we do, from how we develop and manage our products, to our approach to sales and customer success, and supporting business operations. At its core, this approach integrates our unique data, expert analysis, and innovative solutions into an integrated suite of client solutions and digital community platforms, designed to serve a broad range of industry markets and customer needs on a global basis. The operational leverage this provides means we can respond rapidly to changing customer needs and market opportunities, and continuously manage and develop products quickly, at scale, with limited capital investment as well as providing unique integration opportunities for M&A.

 

Strategic Priorities  

GlobalData's four strategic priorities are: Customer Obsession, World-Class Product, Sales Excellence and Operational Agility.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUORRRVWUAAUR
Date   Source Headline
11th Sep 20177:00 amRNSDirectorate Change
1st Aug 20177:00 amRNSRevised dividend timetable
31st Jul 20177:00 amRNSUnaudited Interim Report
13th Jun 20175:57 pmRNSTransaction in Own Shares
9th Jun 20179:53 amRNSTransaction in Own Shares
2nd Jun 20175:48 pmRNSTransaction in Own Shares
18th May 20175:40 pmRNSTransaction in Own Shares
11th May 20175:34 pmRNSTransaction in Own Shares
9th May 20173:02 pmRNSTransaction in Own Shares
25th Apr 201712:52 pmRNSAGM Result
25th Apr 20177:00 amRNSAGM Statement
19th Apr 20172:10 pmRNSNew Banking Facilities
24th Mar 20177:00 amRNSAnnual Report and Accounts and Notice of AGM
27th Feb 20177:02 amRNSAppointment of Non-Executive Directors
27th Feb 20177:00 amRNSFinal Results For The Year Ended 31 December 2016
30th Dec 201612:57 pmRNSTransaction in Own Shares
23rd Dec 20163:29 pmRNSTransaction in Own Shares
6th Dec 20165:27 pmRNSTransaction in Own Shares
15th Nov 201611:48 amRNSTransaction in Own Shares
11th Nov 20166:18 pmRNSTransaction in Own Shares
4th Nov 20168:48 amRNSTransaction in Own Shares
28th Oct 20165:23 pmRNSTransaction in Own Shares
21st Oct 20166:04 pmRNSGrant of Options
12th Oct 20166:06 pmRNSTransfer of Shares out of Treasury
23rd Sep 201610:28 amRNSDirector/PDMR Shareholding
25th Jul 20167:00 amRNSInterim Results
19th Jul 20169:49 amRNSNotice of Results
19th Jul 20167:00 amRNSDirector Notification
24th Jun 20164:52 pmRNSTransaction in Own Shares
13th Jun 201612:31 pmRNSTransaction in Own Shares
9th Jun 20169:16 amRNSTransaction in Own Shares
17th May 20163:41 pmRNSTransaction in own shares
17th May 201612:28 pmRNSResult of AGM
13th May 20165:01 pmRNSTransaction in Own Shares
18th Apr 20167:00 amRNSTransaction in Own Shares
31st Mar 20167:00 amRNSAnnual Report and Accounts and Notice of AGM
17th Mar 20166:12 pmRNSTransaction in Own Shares
11th Mar 20165:07 pmRNSDirector/PDMR Shareholding
8th Mar 20165:56 pmRNSDirector's Dealings
1st Mar 20167:00 amRNSDirectorate Change
1st Mar 20167:00 amRNSFinal Results
26th Jan 201611:02 amRNSHoldings in Company and Director Shareholding
25th Jan 20168:00 amRNSCompletion of Acquisition and Disposal
19th Jan 20161:31 pmRNSResult of General Meeting
23rd Dec 20157:00 amRNSAcquisition and Disposal
18th Dec 20157:00 amRNSPossible Acquisition and Disposal
1st Sep 20157:03 amRNSCompletion of Acquisition
27th Jul 20157:01 amRNSInterim Results
27th Jul 20157:00 amRNSAcquisition of Business Assets from Informa plc
21st Apr 201512:52 pmRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.